Abstract
Long-term drug therapy is the most common method of treatment for controlling seizures in patients with epilepsy. In 1990, there were only 5 frequently used antiepileptic drugs (AEDs) being prescribed in the US. Now, that number has more than doubled and additional candidates are awaiting regulatory approval or are in the development pipeline. While the increase in the number of agents available has increased the treatment options for physicians and patients, it has also made appropriate drug selection for an individual patient more difficult. The spectrum of activity of new AEDs in the context of which patients will benefit from these drugs was reviewed at a symposium session of the American Epilepsy Society Annual Meeting [ Boston, US; December 1997 ].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
